Spyre Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,984,536 | 3.78% |
VC/PE Firms | 5,716,466 | 10.9% |
Hedge Funds | 7,276,461 | 13.9% |
Institutions | 37,457,805 | 71.4% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1154.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,507,983 | US$199.5m | 14% | 0.01% | |||
4,018,101 | US$106.8m | 962% | 9.47% | |||
3,258,360 | US$86.6m | 45.9% | 1.26% | |||
3,031,018 | US$80.5m | 18.6% | 1.86% | |||
2,685,448 | US$71.4m | 23.7% | 3.22% | |||
2,514,538 | US$66.8m | 388% | 3.09% | |||
2,403,441 | US$63.9m | 332% | no data | |||
1,988,084 | US$52.8m | 5.52% | 3.47% | |||
1,911,566 | US$50.8m | 284% | no data | |||
1,839,138 | US$48.9m | 0% | 0.6% | |||
1,756,667 | US$46.7m | 44.8% | 1.23% | |||
1,409,659 | US$37.5m | 949% | no data | |||
1,152,411 | US$30.6m | 4.27% | 0.06% | |||
880,804 | US$23.4m | 267% | 0.01% | |||
795,946 | US$21.1m | -2.08% | no data | |||
765,834 | US$20.3m | 132% | no data | |||
746,907 | US$19.8m | 0% | no data | |||
741,904 | US$19.7m | 0% | 0.01% | |||
707,586 | US$18.8m | 0% | 0.02% | |||
696,480 | US$18.5m | 179% | 0.89% | |||
687,080 | US$18.3m | 0% | 0.12% | |||
673,867 | US$17.9m | 4,720% | 0.01% | |||
666,000 | US$17.7m | 42.9% | 0.11% | |||
575,000 | US$15.3m | 130% | 1.69% | |||
513,420 | US$13.6m | 25.2% | 2.28% |